Filing Flows › Comparisons › OGN vs ALNY
Organon vs Alnylam Pharmaceuticals: OGN and ALNY compared
Organon is the larger company: $1.6B of revenue in its latest quarter (Q3 2026) against $1.5B for Alnylam Pharmaceuticals (Q3 2026). Alnylam Pharmaceuticals is growing faster (+17% against -2% a year earlier). Alnylam Pharmaceuticals is more profitable, with an operating margin of 23.7% against 16.2%.
Where the money goes: OGN and ALNY
Organon (OGN) · Q3 2026
Organon, Q3 2026: revenue $1.6B (-2% year over year), operating margin 16.2%, net earnings $164M, operating cash flow $370M. The chart follows the revenue to costs, profit and cash.
Alnylam Pharmaceuticals (ALNY) · Q3 2026
Alnylam Pharmaceuticals, Q3 2026: revenue $1.5B (+17% year over year), operating margin 23.7%, net earnings $2.2B, operating cash flow $341M. The chart follows the revenue to costs, profit and cash.
| Organon (OGN) | Alnylam Pharmaceuticals (ALNY) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $1.6B | $1.5B |
| Revenue growth, Y/Y | -2% | +17% |
| Gross margin | 55.2% | — |
| Operating margin | 16.2% | 23.7% |
| Net earnings | $164M | $2.2B |
| Net margin | 10.4% | 148.6% |
| Operating cash flow | $370M | $341M |
| Free cash flow | $326M | $271M |
| Market value | $3.8B | $21.6B |
| P/E | 18.0× | 8.0× |
| Analysts’ mean target | $10.33 | $302.48 |
Where the revenue comes from
Alnylam Pharmaceuticals
- Net product revenues: $1.3B (89%)
- Total Rare: $142M (10%)
- ONPATTRO: $19.6M (1%)
Questions
Which is bigger, Organon or Alnylam Pharmaceuticals?
Organon is the larger company: $1.6B of revenue in its latest quarter (Q3 2026) against $1.5B for Alnylam Pharmaceuticals (Q3 2026).
Is Organon or Alnylam Pharmaceuticals growing faster?
Alnylam Pharmaceuticals is growing faster (+17% against -2% a year earlier).
Which is more profitable, Organon or Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals is more profitable, with an operating margin of 23.7% against 16.2%.
More: Organon earnings · how Organon makes money · Alnylam Pharmaceuticals earnings · how Alnylam Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 30, 2026; 10-Q filed Oct 29, 2026). Fiscal quarters can end on different dates. Not investment advice.